These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Identification of IY81149 and its metabolites in the rat plasma using the on-line HPLC/ESI mass spectrometry. Myung SW, Min HK, Jin C, Kim M, Lee SM, Chung GJ, Park SJ, Kim DY, Cho HW. Arch Pharm Res; 1999 Apr; 22(2):189-93. PubMed ID: 10230511 [Abstract] [Full Text] [Related]
47. Dose linearity of the pharmacokinetics of the new H+/K(+)-ATPase inhibitor pantoprazole after single intravenous administration. Bliesath H, Huber R, Hartmann M, Lühmann R, Wurst W. Int J Clin Pharmacol Ther; 1994 Jan; 32(1):44-50. PubMed ID: 8199751 [Abstract] [Full Text] [Related]
49. Normal and polar-organic-phase high-performance liquid chromatographic enantioresolution of omeprazole, rabeprazole, lansoprazole and pantoprazole using monochloro-methylated cellulose-based chiral stationary phase and determination of dexrabeprazole. Dixit S, Dubey R, Bhushan R. Biomed Chromatogr; 2014 Jan; 28(1):112-9. PubMed ID: 23616104 [Abstract] [Full Text] [Related]
51. [Chiral separation of tenatoprazole enantiomers using high performance liquid chromatography on vacomycin-bonded chiral stationary phase]. Guan J, Yang J, Bi Y, Shi S, Li F. Se Pu; 2007 Sep; 25(5):732-4. PubMed ID: 18161328 [Abstract] [Full Text] [Related]
52. Validation of an automated liquid chromatographic method for omeprazole in human plasma using on-line solid-phase extraction. García-Encina G, Farrán R, Puig S, Martínez L. J Pharm Biomed Anal; 1999 Nov; 21(2):371-82. PubMed ID: 10703993 [Abstract] [Full Text] [Related]
56. Development of a liquid chromatography/tandem mass spectrometry assay for the quantification of rabeprazole in human plasma. Huang J, Xu Y, Gao S, Rui L, Guo Q. Rapid Commun Mass Spectrom; 2005 Jul 24; 19(16):2321-4. PubMed ID: 16021618 [Abstract] [Full Text] [Related]